Integrated BioPharma Statistics
Total Valuation
INBP has a market cap or net worth of $6.32 million. The enterprise value is $6.34 million.
| Market Cap | 6.32M |
| Enterprise Value | 6.34M |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
INBP has 30.10 million shares outstanding. The number of shares has increased by 2.72% in one year.
| Shares Outstanding | 30.10M |
| Shares Change (YoY) | +2.72% |
| Shares Change (QoQ) | +2.21% |
| Owned by Insiders (%) | 79.76% |
| Owned by Institutions (%) | 0.07% |
| Float | 22.17M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.10 |
| Forward PS | n/a |
| PB Ratio | 0.33 |
| P/FCF Ratio | 67.66 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 11.81, with an EV/FCF ratio of 67.86.
| EV / Earnings | n/a |
| EV / Sales | 0.10 |
| EV / EBITDA | 11.81 |
| EV / EBIT | n/a |
| EV / FCF | 67.86 |
Financial Position
The company has a current ratio of 2.63, with a Debt / Equity ratio of 0.11.
| Current Ratio | 2.63 |
| Quick Ratio | 0.97 |
| Debt / Equity | 0.11 |
| Debt / EBITDA | 3.80 |
| Debt / FCF | 21.83 |
| Interest Coverage | 2.47 |
Financial Efficiency
Return on equity (ROE) is -0.61% and return on invested capital (ROIC) is -0.34%.
| Return on Equity (ROE) | -0.61% |
| Return on Assets (ROA) | -0.43% |
| Return on Capital (ROIC) | -0.34% |
| Revenue Per Employee | $444,312 |
| Profits Per Employee | -$823 |
| Employee Count | 141 |
| Asset Turnover | 2.38 |
| Inventory Turnover | 5.60 |
Taxes
In the past 12 months, INBP has paid $53,000 in taxes.
| Income Tax | 53,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -36.36% in the last 52 weeks. The beta is 0.76, so INBP's price volatility has been lower than the market average.
| Beta (5Y) | 0.76 |
| 52-Week Price Change | -36.36% |
| 50-Day Moving Average | 0.22 |
| 200-Day Moving Average | 0.24 |
| Relative Strength Index (RSI) | 31.58 |
| Average Volume (20 Days) | 215 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | 11,751 |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, INBP had revenue of $62.65 million and -$116,000 in losses. Loss per share was -$0.00.
| Revenue | 62.65M |
| Gross Profit | 3.59M |
| Operating Income | -72,000 |
| Pretax Income | -63,000 |
| Net Income | -116,000 |
| EBITDA | 537,000 |
| EBIT | -66,600 |
| Loss Per Share | -$0.00 |
Balance Sheet
The company has $2.02 million in cash and $2.04 million in debt, giving a net cash position of -$19,000 or -$0.00 per share.
| Cash & Cash Equivalents | 2.02M |
| Total Debt | 2.04M |
| Net Cash | -19,000 |
| Net Cash Per Share | -$0.00 |
| Equity (Book Value) | 18.91M |
| Book Value Per Share | 0.63 |
| Working Capital | 11.32M |
Cash Flow
In the last 12 months, operating cash flow was $456,486 and capital expenditures -$363,062, giving a free cash flow of $93,424.
| Operating Cash Flow | 456,486 |
| Capital Expenditures | -363,062 |
| Free Cash Flow | 93,424 |
| FCF Per Share | $0.00 |
Margins
Gross margin is 5.72%, with operating and profit margins of -0.11% and -0.19%.
| Gross Margin | 5.72% |
| Operating Margin | -0.11% |
| Pretax Margin | -0.10% |
| Profit Margin | -0.19% |
| EBITDA Margin | 0.86% |
| EBIT Margin | -0.11% |
| FCF Margin | 0.15% |
Dividends & Yields
INBP does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 1 |
| Payout Ratio | n/a |
| Buyback Yield | -2.72% |
| Shareholder Yield | -2.72% |
| Earnings Yield | -1.84% |
| FCF Yield | 1.48% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
INBP has an Altman Z-Score of 1.6 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.6 |
| Piotroski F-Score | 4 |